1121661

Maja de Jonge, M.D. — FEI 3016171998

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 6, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rotterdam (Netherlands)

Additional Details

Clinical Investigator (CI)